EARLY / OCCULT EHPVO NO LONGER IDIOPATHIC- UNRAVELLING METABOLIC CLUES IN A PROSPECTIVE STUDY IN ASIAN SCENERIO.

Main Article Content

Zeeshan Ahmad Wani
Rameez Raja Najar
Asif Iqbal
Afrah Nasir
Muzamil Majeed

Keywords

Extrahepatic portal vein obstruction (EHPVO), metabolic syndrome

Abstract

Background: Extrahepatic portal vein obstruction (EHPVO), characterized by occlusion and cavernomatous transformation of the portal vein resulting in portal hypertension. The clinical aspect of EHPVO is well established however its association with metabolic syndrome in adults has not been extensively studied. This study aims to explore the prevalence and components of metabolic syndrome in adult patients diagnosed with occult EHPVO.


Aims and Methods: In this prospective observational study conducted in a tertiary care center in Kashmir, India, 109 adult patients aged 15–75 years with non-cirrhotic, non-malignant EHPVO confirmed by abdominal ultrasonography were evaluated. Metabolic parameters such as body mass index (BMI), hypertension, diabetes or pre-diabetes, dyslipidemia, and hyperuricemia. Clinicoetiological evaluation along with follow-up outcomes, were recorded and analyzed. Statistical analysis was performed using SPSS. Categorical variables were expressed as frequencies and percentages and associations were assessed using the Chi-square test.


Results: Of the 109 patients, 56 (51.4%) were males and 53 (48.6%) females. Median age was 40.25 years . Metabolic evaluation showed normal BMI ,dyslipidemia, pre-diabetes, hypertension, hyperuricemia in 78.9%, 27.5%, 14.7%, 30.3% and 11% respectively. Eighty percent (80%) were idiopathic, with substantial proportion of these patients displayed features of metabolic syndrome, suggesting a potential link between endothelial dysfunction and EHPVO.


Conclusion: This study highlights increased prevalence of metabolic syndrome in early occult EHPVO in Asian population thereby challenges the notion of idiopathic adult EHPVO. This condition however demonstrated a relatively benign course, with no mortality reported during the study’s follow-up period.

Abstract 48 | Pdf Downloads 13

References

1. Sarin SK, Khanna R. Non-cirrhotic portal hypertension. Clin Liver Dis. 2014;18: 451–476.
2. Weiss B, Shteyer E et al. Etiology and long-term outcome of extrahepatic portal vein obstruction in children. World J Gastroenterol 2010; 16(39): 4968-4972
3. Zeeshan A Wani , Riyaz A Bhat et al.Extrahepatic Portal Vein Obstruction and Portal Vein Thrombosis in Special Situations: Need for a New Classification. Saudi J Gastroenterol 2015 May-Jun;21(3):129–138
4. Condat B, Valla D. Nonmalignant portal vein thrombosis in adults Nat Clin Pract Gastroenterol Hepatol. 2006; 3:505–15Sarin SK, et al. Non-cirrhotic portal hypertension: a clinical and pathophysiological review. J Hepatol. 2014;60(2):421–441.
5. Dilawari JB, Chawla YK. Extrahepatic portal venous obstruction. Gut. 1994;35(2):272–276.
6. Sharma M, Rameshbabu CS. Collaterals in portal hypertension. Trop Gastroenterol. 2012;33(2):95–103.
7. Reaven GM. The metabolic syndrome: time to get off the merry-go-round?. J Intern Med. 2011;269(2):127–136.
8. Vanhoutte PM, et al. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009;196(2):193–222.
9. Klop B, et al. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218–1240.
10. Khanna R, Sarin SK. Non-cirrhotic portal hypertension—diagnosis and management. J Hepatol. 2014;60(2):421–441.
11. Sharma R, et al. Metabolic syndrome in patients with portal vein thrombosis: Is there an association? Clin Res Hepatol Gastroenterol. 2021;45(5):101621.
12. Condat B, et al. Current management of portal vein thrombosis. J Hepatol. 2007;46(1):173–179.